More Articles

Access and Evidence

Blockchain: Solution Or Snake Oil?

Ross Davies, (Dec 19, 2018)

The potential of blockchain to better manage RWE and access makes it an exciting prospect. However, pharma first needs to get its head around the practical application.
Patients and Medical

Has Medical Affairs Become A Victim Of Its Own Success?

Ross Davies, (Dec 18, 2018)

As medical affairs mushrooms, new skills and capabilities are urgently needed.
Commercial

Pills? What pills?

Adam Chapman, (Dec 13, 2018)

Three ‘Without The Pill’ Digital Therapeutics You Need To Know About
Patients and Medical

Growing Pains

Hugh Gosling, (Dec 12, 2018)

How companies are scaling up their patient-centric efforts
Access and Evidence

VBCs: Are They Working?

Adam Chapman, (Dec 12, 2018)

Are value-based contracts actually improving patient access to new medicines?
Commercial

The Bigger Picture

Adam Chapman, (Dec 11, 2018)

Merck’s Chief Medical Officer reflects on his career thus far and weighs in on the industry’s biggest opportunities and challenges.
Patients and Medical

Made to Measure

Hugh Gosling, (Dec 11, 2018)

After many years of patient-centric efforts, pharma is finally starting to measure its impact
Access and Evidence

Calling the Shots?

Katie Osborne, (Dec 10, 2018)

How influential are the value assessments from bodies like ICER?
Access and Evidence

Cutting Out the Middleman

Hugh Gosling, (Dec 7, 2018)

Are PBMs part of the problem or the solution?
Patients and Medical

My Employer Intervened When It Mattered Most

Lucy Fulford, (Dec 5, 2018)

After being diagnosed with breast cancer, Jane Shaw embarked on a propitious treatment regimen. She has her industry to thank for that.

Pages